CD20-AND EGFR-BINDING PROTEINS ENHANCED STABILITY

The invention provides CD20-binding proteins and EGFR-binding proteins having a reduced tendency to aggregate. Compositions and methods of use are also provided. L'invention concerne des protéines de liaison à CD20 et des protéines de liaison à EGFR ayant une faible tendance à s'agréger. L...

Full description

Saved in:
Bibliographic Details
Main Authors TROUT, BERNHARDT, LEVY, SCHNEIDER, CURTISS, PAUL, AGRAWAL, NEERAJ, JAGDISH
Format Patent
LanguageEnglish
French
Published 03.04.2014
Subjects
BABY COMFORTERS
CHEMISTRY
CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES
DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY
DEVICES FOR RECEIVING SPITTLE
DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The invention provides CD20-binding proteins and EGFR-binding proteins having a reduced tendency to aggregate. Compositions and methods of use are also provided. L'invention concerne des protéines de liaison à CD20 et des protéines de liaison à EGFR ayant une faible tendance à s'agréger. L'invention concerne également des compositions et des méthodes d'utilisation associées.
Bibliography:Application Number: WO2013US62114